Introduction
Environmental chemical exposure remains a major global public health problem. The United States Environmental Protection Agency (EPA) estimates that thousands of chemicals are in use, but only a fraction have detailed toxicological data. Over 200 environmental chemicals can be detected in the blood and urine of the general population of the United States (Centers for Disease Control and Prevention, 2017; Buser and Ingber, 2017) . It is estimated that nearly 25-33% of the global disease burden can be attributed to environmental risk factors. (Smith et al., 1999) Globally, the World Health Organization calculated that pollution is responsible for nearly 7 million deaths per year (World Health Organization, 2016) . Patterns of environmental exposure differ across countries geographically and by per capita income levels, but environmental exposure remains a major cause of morbidity and mortality worldwide (Landrigan et al., 2016) .
Children are particularly susceptible to environmental exposures compared to adults (Firestone and Amler, 2003) . Firstly, children consume more food, water, and air per pound of body weight compared to adults and therefore are proportionally exposed to more environmental toxicants (Au, 2002 , Firestone and Amler, 2003 , Sly and Flack, 2008 . Moreover, an individual's susceptibility to environmental chemical exposure is greatest during "windows of vulnerability," the specific time periods when complex organs, pathways, and connections are being established (i.e. prenatal and early life development) (Selevan et al., 2000) . Exposure to environmental chemicals during these periods can impact cell signaling and alter development. Due to physiological differences between children and adults, children more easily absorb toxicants such as lead, and have decreased elimination abilities. The blood-brain barrier is not fully developed for the first 36 months of life, leaving young children more susceptible to neurotoxicants (Sly and Flack, 2008) . Taken together, these facts suggest that environmental chemical exposure in childhood poses substantial public health concern.
There is evidence to suggest that environmental exposures play a role in the development of Chronic Kidney Disease (CKD), a disease defined by reduced glomerular filtration rate, increased urinary albumin excretion, or both (Jha et al., 2013) . CKD poses a significant and worldwide public health problem, therefore identification of preventable risk factors for CKD, including childhood environmental exposures, could contribute to a decrease in worldwide CKD incidence. CKD has a global prevalence of approximately 10.4% in men and 11.8% in women (Mills et al., 2015) . Currently, CKD mortality is increasing worldwide. (Rhee and Kovesdy, 2015; GBD 2013 Mortality and Causes of Death Collaborators, 2015) . , the prevalence of CKD in the United States is 13.1% (U.S. Renal Data System, 2013). Various studies have estimated a CKD prevalence of 15-74.7 cases per million children Warady and Chadha, 2007) . Children with CKD are at risk for increased morbidity and mortality, and poorer quality of life . The prevalence of End Stage Renal Disease (ESRD), a stage of chronic irreversible renal failure, in children (aged 19 and younger) has increased by 10.1% since 2000 (U.S. Renal Data System, 2013). ESRD in childhood carries a significant physical and emotional impact, and all-cause hospitalizations in this population is increasing, as is ESRD mortality among younger children (U.S. Renal Data System, 2013). The life expectancy for children with ESRD with dialysis treatment is poor, and mortality rates are 30-150 times higher than the general pediatric population (Warady and Chadha, 2007; McDonald et al., 2004) . Kidney transplantation is the treatment of choice for children with ESRD.
Several environmental exposures, including metals such as lead and cadmium are known nephrotoxicants with clear associations with kidney disease (Soderland et al., 2010) . Some metals such as cadmium and lead are associated with increased levels of biomarkers of poor kidney function in adults (Navas-Acien et al., 2009; Buser et al., 2016) . Early studies demonstrated an association between increased levels of metals such as mercury in the kidneys of stillborn children (Lutz et al., 1996) . Environmental arsenic exposure is associated with kidney disease outcomes in adults (Zheng et al., 2014) as well as in adolescents and young adults (Weidemann et al., 2015a) . A study from Bangladesh found that maternal arsenic exposure was associated with a decrease in infant kidney function, although this was not statistically significant (Hawkesworth et al., 2013) . A study from Chile found that adults with in utero and childhood exposure had a higher risk of chronic renal disease (Smith et al., 2012) . Studies in the United States have found that higher blood lead levels are associated with a decrease in kidney function in children and teenagers (Fadrowski et al., 2010) .
However, there remains limited research regarding environmental exposures in children, as most of the research into environmental risk factors for CKD has been conducted in adult populations (Weidemann et al., 2015b) . Several narrative reviews of environmental exposures and pediatric renal disease (Chadha and Warady, 2005 , Warady and Chadha, 2007 , Soderland et al., 2010 , Weidemann et al., 2015b , Kataria et al., 2015b have been recently published, but not yet as a systematic review.
To evaluate the potential relationship between environmental exposures and kidney function outcomes in children, such as estimated glomerular filtration rate (GFR), proteinuria, albuminuria, and urinary biomarkers of tubular damage such as β-2-microglobulin and N-acetyl-β-D-glucosaminidase (NAG), we conducted a review of epidemiologic studies that have previously investigated the association between any environmental exposure via geography, environment, or biomarkers, and CKD endpoints. We also considered studies featuring urinary markers of kidney damage, such as β-2-microglobulin (β2MG), Nacetyl-β-D-glucosaminidase (NAG), α-1-microglobulin (A1M) and retinol binding protein (RBP), as well as many other biomarkers.
Materials and methods
We searched the PubMed (http://www.ncbi.nlm.nih.gov/pubmed) database to find published observational studies that evaluated the relationship between an environmental exposure and CKD status and/ or kidney function markers. We used free text as well as Medical Subject Heading (MeSH) terms (Fig. 1) . The search period was through July 2016 with no language restrictions. Eleven studies were identified manually (Gossner et al., 2009 , Guan et al., 2009 , Hawkesworth et al., 2013 , Hu, 1991 , Kooijman et al., 2015 , Loghman-Adham, 1998 , Moel and Sachs, 1992 , Noonan et al., 2002 , Ramirez-Rubio et al., 2015 , Weidemann et al., 2015a . Two investigators independently reviewed each publication identified through the search and applied the study selection criteria. Epidemiologic studies with individual level or community level data on environmental exposures were included. Reviews, case series and case reports, animal and experimental studies, studies without an environmental exposure or a kidney disease outcome, and studies in non-children populations were excluded.
The two investigators (LZ and APS) independently abstracted the study data, including design, location, age and gender distribution, sample size, biomarker assessment, outcome ascertainment, exposure levels, study results, and adjustment factors. Studies were classified as those conducted with metals or "other" as the environmental exposure (s) of interest. For studies with multiple levels of adjustment, we abstracted and reported the measure of association adjusted for the most covariates. Study quality was evaluated using criteria reported by Longnecker et al. (1988) as performed in previous systematic reviews (Zheng et al.,2014) . We confirmed our criteria with the PRISMA checklist for completeness of systematic review findings (Moher et al., 2010) .
The authors concluded that the studies were of limited quality and too diverse in outcome measures, exposure levels, and too diverse in exposures to allow for meaningful meta-analysis of all studies (Pittler, 2002) . Data were abstracted for summary tables and study quality evaluation tables and categorized by exposure types.
Results
There were a total of 50 studies published between 1979 and 2016 that met our inclusion criteria (Fig. 2 ). Most were published in English, four (4) were published in Russian and two (2) were published in Chinese. These publications were translated by Russian or Chinese speakers before inclusion. Some publications were considered together (Bellinger et al., 2006; Geier et al., 2013; Hawkesworth et al., 2013; Barregard et al., 2008; DeRouen et al.,2006; Skroder et al., 2015; Woods et al., 2008; Kooijman et al., 2015; Taal et al., 2011) , as they used the same study population and provided complementary information. Most studies were from non-occupationally-exposed populations, one included children of occupationally exposed parents (Khan et al., 2010) . The studies were conducted in the United States, Canada, L.Y. Zheng et al. Environmental Research 158 (2017) 625-648 Germany, Czech Republic, Poland, Kosovo, Pakistan, Senegal, Belgium, Morocco, France, Portugal, Pakistan, China, Bangladesh, Mexico, Thailand, Egypt, and Netherlands. The study designs included 32 crosssectional, 6 prospective cohort, 2 retrospective cohort, 4 case-control, and 2 randomized clinical trials (representing 6 publications) (Tables  1-4) .
Quality assessment
A majority of studies measured exposure at the individual level using blood or urine biomarkers. Four (4) studies did not measure the exposure at an individual level, these studies measured proximity to a high exposure source (Lagutina et al., 1979 , Ignatova et al., 1996 , D'Andrea and Reddy, 2014 . Four (4) studies reported multiple exposures, such as lead and cadmium (Chan et al., 2012 , Fels et al., 1998 , or cadmium and mercury (Laamech et al., 2014 , de Burbure et al., 2006 . Outcome measure definitions were generally consistent. Most studies measured urine protein, urine albumin levels, or other biomarkers such as β2-microglobulin (β2MG), N-acetyl-β-D-glucosaminidase (NAG), α-1-microglobulin (A1M), and some other small low-molecular weight biomarkers. One study used a dipstick to measure proteinuria (Factor-Litvak et al., 1999) . Among the studies that examined estimated glomerular filtration rate (eGFR), seven studies used creatinine based estimating equations (Fadrowski et al., 2010 , Farzan et al., 2016 , Garcia-Esquinas et al., 2013 , Kataria et al., 2015a , Kooijman et al., 2015 , Loghman-Adham, 1998 , Watkins et al., 2013 . Four studies used Cystatin C based estimating equations to determine eGFR (Fadrowski et al., 2010 , Skroder et al., 2015 , Hawkesworth et al., 2013 , Filler et al., 2012 . One study used an equation based on both creatinine and Cystatin C (Weaver et al., 2014) . One study used measured GFR by plasma disappearance of iohexol. Not all studies adjusted for possible confounders such as age, gender, race/ethnicity, or BMI Z-scores (Tables 5-8 ). Overall, we found studies of high quality (with adjustment for possible confounders and standardized exposure and outcome assessment) as well as studies of low quality (lack of adjustment for potential confounders, no individuallevel exposure assessment, and nonstandard outcome metrics).
Lead exposure and kidney disease outcomes
We found 16 studies that examined children's lead exposure and kidney health. The studies were published between 1985 and 2016 and were conducted in the United States, Canada, Czech Republic, Poland, Hong Kong Germany, Romania, Kosovo, Belgium, Pakistan, Senegal, and Morocco (Table 5 ). The study designs included 12 cross-sectional, 2 prospective cohort, and 2 case-control studies. The studies published before 1999 had small sample sizes and did not adjust for possible confounders. Nearly all studies of lead exposure used blood lead as a biomarker, although Scharer et al. (1991) used lead levels measured in deciduous teeth. Reported mean blood lead levels ranged from 2.9 µg/ dL in a United States population (Fadrowski et al., 2010) to 34.2 µg/dL in Romania (Verberk et al., 1996) . Nine (9) studies reported significant associations between lead and kidney disease measures. In a cross-sectional study of 195 children in the Czech Republic, urine retinol binding protein (RBP) was associated with lead levels, but no other biomarkers ( blood cadmium, zinc protoporphyrin) were associated with RBP levels (Bernard et al., 1995) . Otherwise, no association was found between cadmium levels and RBP, B2MG, or albumin levels (Bernard et al., 1995) . A cross-sectional study of 112 children in Poland reported a higher level of urine β2MG in exposed compared to unexposed participants but no other biomarkers were different by exposure status (Fels et al., 1998) . A cross-sectional study of 58 children in Senegal found that children exposed to lead (via industrial exposure) had higher levels of urine albumin and protein than unexposed children (Cabral et al., 2012) . A cross-sectional study of 2209 children from Hong Kong reported a positive correlation between urine lead levels and urine albumin, but observed a negative correlation between blood lead and urine albumin (Chan et al., 2012) . A crosssectional study from Canada reported a weak but statistically significant association between increased blood lead levels and decreased eGFR (Filler et al., 2012) . A case-control study of 58 children in Germany found that levels of tooth lead were higher in children with renal disease with pre-existing CKD including some who were dialysis-dependent as compared to controls (Scharer et al., 1991) . However, these studies did not include adjustment for possible confounders. A crosssectional study of 279 children in Kosovo also reported an increased odds of proteinuria in the industrial town of Kosovoka Mitrovica, compared to the nonindustrial town of Pristina 25 miles away (FactorLitvak et al., 1999) . In this study, pregnant women were initially recruited at government clinics. Children were selected for follow-up based on umbilical cord lead, town of residence, and location. This study is one of the few with significant positive associations that adjusted for possible confounders. In a cross-sectional study of 200 children in Belgium, there was a 3.6 (95% CI: 1.5, 5.7) percent increase in Table 2 for cadmium results.
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< 0.7 ng/mL 0.7-1.0 ng/mL 1.0-1.5 ng/mL ≥ 1.5 ng/mL PFHxS < 1 ng/mL 1-2 ng/mL 2-3.95 ng/mL Environmental Research 158 (2017) serum cystatin C per unit increase in blood lead and a 16.0 (95% CI: 2.7, 31) percent increase in urine β2MG per unit increase in blood lead (Staessen et al., 2001 ). The findings were also adjusted for possible confounders. Another cross-sectional study of 736 children in Belgium also found an increase in urine β2MG levels with increased urine lead (Chaumont et al., 2012) . However, the results were adjusted for many interaction variables in addition to possible confounders, making a direct comparison with other studies difficult. Seven (7) studies of blood lead and kidney disease measures reported mostly null associations, or lacked statistically significant evidence of a relationship with kidney disease markers. A case-control study from the United States found no difference in creatinine clearance in children with lead poisoning (exposure levels 100-471 μg/dl) compared to sibling controls (Moel et al., 1985) . A cross-sectional study of 196 children in Morocco found no significant correlations between blood lead and urine RBP and albumin levels (Laamech et al., 2014) . A cross-sectional study of 246 children in Pakistan also found no significant difference in serum urea or serum creatinine levels between exposed (children of lead-exposed industrial workers) and unexposed (children of non-exposed workers) groups (Khan et al., 2010) . A crosssectional study of 151 children in Romania found no significant increases in biomarkers associated with blood lead, except for an increase in urine NAG (Verberk et al., 1996) . A cross-sectional study of 134 children in the United States did not find differences between eGFR in unexposed or exposed (exposure levels 48-471 μg/dl) children (Loghman-Adham, 1998) . However, these studies did not control for possible confounders. A cross-sectional study of 769 children in the United States found a dose-response decrease in eGFR with increasing blood lead levels, but their results were not statistically significant (Fadrowski et al., 2010) . This was a study in the general United States population which used standardized definitions and controlled for possible confounders (Fadrowski et al., 2010) . The same authors also reported a decrease in measured GFR in a prospective cohort study of 391 American and Canadian children with CKD but this was also not significant . Both studies by Fadrowski et al. had larger study populations and adjusted for possible confounders, they are examples of high quality studies in this systematic review. Overall, there is some evidence that lead exposure is associated with various kidney disease outcomes.
Other metals and kidney disease outcomes
We found 15 publications representing 12 different studies on various other metals and kidney disease outcomes, particularly those with arsenic (Skroder et al., 2015; Hawkesworth et al., 2013) , cadmium (Chan et al., 2012 , de Burbure et al., 2006 , Hossny et al., 2001 , Swaddiwudhipong et al., 2015 Weaver et al., 2014; Skroder et al., 2015; Noonan et al., 2002) . manganese (Nascimento et al., 2016) , mercury (Barregard et al., 2008; de Burbure et al., 2006; Woods et al., 2008; Geier et al., 2013; Bellinger et al., 2006; DeRouen et al., 2006) ,selenium (Skroder et al., 2015) , thallium (Weaver et al., 2014) , or uranium (Weaver et al., 2014) (Table 2 ). These studies covered Egypt, France, Poland, Czech Republic, Portugal, China, Bangladesh, Mexico, Thailand, Brazil, and the United States. The study designs included 8 cross-sectional, 1 prospective cohort, and 2 randomized clinical trials (represented in 5 publications). Seven (7) studies examined the renal effects of cadmium exposures. Studies of cadmium exposure reported both positive and mixed results. A cross-sectional study of 112 children in Poland reported a higher level of urine β2MG in exposed compared to unexposed participants but no other biomarkers were different by exposure status (Fels et al., 1998) . A cross-sectional study of 405 children in Egypt found that adolescents who were urine AIM positive had higher blood cadmium levels than those who were not, but null associations were identified between A1M and blood cadmium levels in school aged children (Hossny et al., 2001) . A cross-sectional study of 804 children from France, Poland, and the Table 4 Epidemiological studies based on proximity to exposure source and kidney function biomarkers.
Reference and Country
Age, % male Zheng et al. Environmental Research 158 (2017) 625-648 Table 6 Quality assessment criteria for the evaluation of design and data analysis in epidemiologic studies of metals other than lead and kidney function biomarkers. Environmental Research 158 (2017) 625-648 Table 7 Quality criteria for the evaluation of design and data analysis in epidemiologic studies of non-metal environmental exposures and kidney function biomarkers. Environmental Research 158 (2017) 625-648 Czech Republic reported statistically significant increases in urine RBP and NAG with increased blood and urine cadmium. Their study population was large and the analysis used multiple linear regression models that selected covariates with stepwise regression (de Burbure et al., 2006) . However, they adjusted for several interaction terms (such as with mercury levels), making comparison with other studies difficult. A cross-sectional study of 2209 children from Hong Kong reported a positive correlation between urine cadmium levels and urine albumin, but observed a negative correlation between blood cadmium and urine albumin, suggesting that blood levels of cadmium may not be suitable for estimating intrarenal exposure (Chan et al., 2012) . A cross-sectional study of 159 children from the United States found positive correlations between urine cadmium and NAG, albumin, and alanine aminopeptidase (AAP) levels, although these were not statistically significant (Noonan et al., 2002) . A cross-sectional study of 512 children in Mexico reported an increase in eGFR per doubling of urine cadmium (Weaver et al., 2014) . A cross-sectional study of 594 children in Thailand reported significantly increased odds of elevated β2MG among individuals who experienced higher levels of urine and blood cadmium compared to those with lower levels (Swaddiwudhipong et al., 2015) . Notably, these two studies were of high quality, and had a large number of study participants (> 500) and adjusted for possible confounders. Overall, there is suggestive evidence of an effect of early life cadmium exposure on renal health outcomes. Six publications representing three separate studies assessed the effects of mercury exposure. These include two randomized clinical trials: the New England Children's Amalgam Trial in the United States (Barregard et al., 2008; Bellinger et al., 2006) , and the Casa Pia study in Portugal (DeRouen et al., 2006; Geier et al., 2013; Woods et al., 2008) . The New England Children's Amalgam Trial randomized children to either amalgam (containing mercury) or composite (no mercury) dental treatments (Bellinger et al., 2006) . The Casa Pia study randomized children to either amalgam (containing mercury) or to resin (no mercury) dental treatments (DeRouen et al., 2006) . There was also a crosssectional study conducted in parts of France, Poland, and the Czech Republic (de Burbure et al., 2006) . The Casa Pia study of 507 children reported no significant difference in urine albumin levels by treatment year (Derouen et al., 2006) , but other investigators demonstrated an increase in urine albumin per log-increase in the children's urine mercury levels (Woods et al., 2008) . A secondary analysis reported a statistically significant increase in urine GST-α and GST-π levels per increase in tooth restorations (Geier et al., 2013) . However, the methods and post-hoc design of this study are questionable for several reasons, including the use of an exploratory method that uses the data to suggest how to configure the model, as opposed to taking advantage of the Casa Pia's randomized clinical trial design, and the use of GST-α and GST-π levels as a primary outcome (DeRouen et al., 2015) . In the New England Children's Amalgam Trial of 534 (Bellinger et al., 2006 ) children comparing amalgam (proxy for mercury exposure) versus composite dental treatments, the OR (95% CI) of albuminuria comparing amalgam versus composite was 1.8 (1.1, 2.9) (Barregard et al., 2008) . This was a large randomized clinical trial design, and the study adjusted for potential confounders. A cross-sectional study of 804 children from France, Poland, and the Czech Republic reported statistically significant increases in serum β2MG and urine NAG with increased urine mercury. Their study population was large and the analysis used multiple linear regression models that selected covariates with stepwise regression (de Burbure et al., 2006) . However, they adjusted for several interaction terms with other metals (such as cadmium), making comparison with other studies difficult.
Two publications representing one study assessed the effects of arsenic. A prospective cohort study of 1334 children in Bangladesh found that urine arsenic is associated with a decrease in children's eGFR per unit increase in maternal urine arsenic, although this was not significant (Hawkesworth et al., 2013) . There was also an association between the child's urine cadmium and decreased eGFR (Skroder et al., Table 8 Quality criteria for the evaluation of design and data analysis in epidemiologic studies of proximity to contaminated areas and kidney function biomarkers. Zheng et al. Environmental Research 158 (2017 ) 625-648 2015 . No change in children's eGFR was reported per unit increase in the child's urine selenium or arsenic in a cross-sectional analysis of the cohort (Skroder et al., 2015) . One study reported on the effects of thallium and uranium. A cross-sectional study of 512 children in Mexico reported an increase in eGFR per doubling of urine thallium but not for urine uranium (Weaver et al., 2014) . One study reported on the effects of manganese. A cross-sectional study of 63 children in Brazil found a significant increase in urine albumin and urine NAG levels between urban and rural children, with rural children having higher levels of blood, hair, and drinking water manganese (Nascimento et al., 2016) . However, this study was comprised of a small number of participants and did not control for potential confounders for kidney function biomarkers (Nascimento et al., 2016) .
Non-metal environmental exposures
We identified 17 studies that examined non-metal environmental exposures. These include studies of fluoride levels (Xiong et al., 2007; Liu et al., 2005) , aflatoxin (Hassan et al., 2006a) and ochratoxin (Hassan et al., 2006b) , maternal smoking levels (Taal et al., 2011 , Kooijman et al., 2015 , secondhand smoking (Garcia-Esquinas et al., 2013) , Bisphenol A , Triclosan, Benzophenone-3 (Trasande et al., 2013) , PFOA (Geiger et al., 2013; Watkins et al., 2013; Kataria et al., 2015a) , Bisphenol-A-glycidyl-dimethacrylate (bisGMA) (Trachtenberg et al., 2014) , melamine exposure (Lam et al., 2008; Guan et al., 2009) , polycyclic aromatic hydrocarbons (PAHs) (Farzan et al., 2016) and various phthalate compounds (Trasande et al., 2014 , Tsai et al., 2016 ( Table 3 ). The study designs included 12 cross-sectional, 1 case control, 2 prospective cohort, 1 retrospective cohort, and 1 randomized clinical trial.
Two studies investigated the association of fluoride exposure, including 1 cross-sectional and 1 case-control. In a cross-sectional study of fluoride exposure in 210 children in China, the investigators found increases of urine NAG and urine γ-GT levels (Liu et al., 2005) . In casecontrol study of fluoride levels in 210 children in China, slightly higher urine NAG levels were found in participants with higher serum fluoride levels (Xiong et al., 2007) . While both studies were from China, the first study did not offer adjustment for confounders while the second study matched on age, sex, and nutritional status. One cross-sectional study investigated the effects of Aflatoxin and Ochratoxin exposure. A crosssectional study of 50 mother-child pairs in Egypt found no statistically significant differences in children's urine β2MG or urine albumin levels between individuals with negative and positive maternal Aflatoxin exposure. (Hassan et al., 2006a) . However, they found higher levels of urine β2MG in children with maternal Ochratoxin A levels (Hassan et al., 2006b ).
Three publications representing two studies, a cross-sectional and a prospective cohort, investigated smoking exposures assessed via questionnaire. A prospective cohort study of 538 children in the Netherlands found that maternal smoking was associated with decreased kidney volume at age 2, although this was not statistically significant (Taal et al., 2011) . The same prospective study followed the children to age 6 and found that maternal smoking was associated with both decreased child eGFR and increased albumin-creatinine ratio (ACR) when the mother continued to smoke ≥5 cigarettes per day during preganancy (Kooijman et al., 2015) . This study also found an association between paternal smoking and smaller combined kidney volume at age 6, although there was not association with eGFR and ACR (Kooijman et al., 2015) .
A cross-sectional study of 7516 children in the United States found that serum cotinine levels (a biomarker of smoking exposure) were associated with a decrease in eGFR. This was present at the highest levels of cotinine indicate of secondhand smoke as well as the higher levels of smoke exposure associated with active smoking (GarciaEsquinas et al., 2013) . This study was conducted in the general US population and controlled for possible confounders.
Two studies, a randomized trial and a cross-sectional study examined the exposure of Bisphenol A. In a randomized trial of 410 children in the New England Children's Amalgam Trial in the United States, of dental interventions (as a proxy for bisphenol-A-glycidyl-dimethacrylate (bisGMA) compounds), the use of preventive dental sealant was associated with an increased odds ratio of microalbuminuria (urine albumin > 30 mg/g) and that composite and copolymer treatments were associated with an increased OR of high urine NAG levels (Trachtenberg et al., 2014) , however, the results were not significant. A cross-sectional study of 667 children in the United States found a slight increase in albumin/creatinine ratio but no increased odds of micro/ macroalbuminuria by Bisphenol A levels (Trasande et al., 2013) . This study also reported that triclosan and benzophenone-3 were not associated with albumin/creatinine ratio (Trasande et al., 2013) .
Two studies, both cross-sectional, examined phthalate exposure. A cross-sectional study of 667 children in the United States found that urine high molecular weight (HMW) phthalates and the HMW phthalate di-2-ethylhexylphthalate (DEHP) were associated with increases in urine albumin/creatinine ratio (Trasande et al., 2014) . This study was also conducted in general US populations and controlled for possible confounders. Meanwhile, a cross-sectional study of 195 children in Taiwan found an association between the phthalate metabolite DEHP and increased urine albumin/creatinine ratio as well as in increased prevalence of microalbuminuria in those exposed to higher levels of DEHP. However, they did not find a significant difference in urine NAG levels (Tsai et al., 2016) . This study also controlled for possible confounders (Tsai et al., 2016) .
Three studies, two cross-sectional and a retrospective cohort, investigated perfluorooctanoic acid (PFOA) exposure. A cross-sectional study of 1772 children in the United States found an association with serum PFOA and perfluorooctane sulfonate (PFOS) levels and odds of hyperuricemia only at the highest levels of exposure (Geiger et al., 2013) . Similarly, another cross-sectional study of 1960 children in the United States found that serum PFOA was only associated with decreased eGFR in the highest quartile of exposure and serum PFOS was associated with a decrease in eGFR in all quartiles of exposure (Kataria et al., 2015a) . The investigators did not find an association between perfluorononanoic acid (PFNA) and perfluorohexane sulfonate (PFHxS) and decreased eGFR (Kataria et al., 2015a) . Meanwhile, a retrospective cohort study of 9660 children in the United States found that blood PFOA, PFOS, PFNA, PFHxS were associated with a decrease in eGFR (Watkins et al., 2013) . All of these studies utilized a large study population and controlled for possible confounders. Taken together, these studies suggest that there is a possible association between PFOA compounds and decreased kidney function in children.
Two studies examined melamine exposure. One cross-sectional study of 3170 children in China examined the consumption of melamine-contaminated milk products. They found that there was a 1.86% prevalence of proteinuria (Lam et al., 2008) . However, this study did not adjust for potential confounders. Another study of 589 children in China found a strong association between kidney stones and melamine content in formula, with adjusted odds ratios of 2.0 (0.6, 3.2) and 7.0 (2.1, 23.00) with comparing moderate and high melamine content in formula to children with no melamine in their formula (Guan et al., 2009) . For children with suspected stones, they reported an adjusted odds ratio of 1.7 (0.9, 3.2) and 2.6 (1.2, 5.4) comparing moderate and high melamine content in formula to children with no melamine in their formula (Guan et al., 2009) .
One cross-sectional study examined PAH exposure. A cross-sectional study of 660 children in the United States found that out of 10 PAH compounds, only 3-Hydroxyphenanthrene was associated with a statistically significant decrease in eGFR in children (Farzan et al., 2016) . All other PAH metabolites were not significantly associated with a decrease in eGFR or an increase in albumin/creatinine ratio (Farzan et al., 2016) .
Proximity studies
There were four studies that examined kidney outcomes with respect to proximity to specific area. Three of these studies are from Russia (and former Soviet Union) (Lagutina et al., 1979 , Ignatova et al., 1996 , Rakhmain Iu et al., 2004 . The study designs included 2 crosssectional, 1 retrospective cohort, and 1 case-control. A cross-sectional study of 1790 children in the former Soviet Union found that the prevalence of kidney and other related abnormalities was higher in polluted areas than non-polluted areas (Lagutina et al., 1979) . A crosssectional study of 486 children in Russia found elevated kidney damage biomarkers (proteins, NAG) were more frequently seen in children living closer to industrial plants (Rakhmanin et al., 2004) . A casecontrol study of 95 children in Russia found that urine heavy metal salt excretion increased in areas with heavy metal contamination compared to control areas (Ignatova et al., 1996) . On the other side of the world, a retrospective cohort study of 312 children in the United States found similar levels of blood urea nitrogen (BUN) and serum creatinine comparing children from areas with and without industrial contamination (D'Andrea and Reddy, 2014) However, none of these studies included adjustment for possible confounders.
Discussion
CKD is a growing public health problem worldwide and its incidence is increasing (Jha et al., 2013) . Evidence of kidney effects of some environmental chemicals has been investigated in other systematic analyses for both arsenic (Zheng et al., 2014) and cadmium (Byber et al., 2016) in adult populations. The systematic review herein evaluated the current body of literature regarding environmental chemical exposures and pediatric renal outcomes. Some of the studies in this review provide evidence of an association with environmental exposures and impaired children's renal function. Since environmental exposures may to some extent represent a modifiable risk factor for pediatric kidney disease, of which few currently exist, the design and implementation of epidemiological studies may ultimately contribute to the prevention of CKD progression. A systematic appraisal of the literature showed mixed evidence of an association between lead exposure and pediatric kidney disease markers, whether defined as eGFR, urine protein, urine albumin, or other kidney damage biomarkers. We found nine studies that reported a positive association of blood lead levels with kidney damage biomarkers such as RBP, β2MG, and proteinuria status. However, seven additional studies did not report an association of blood lead with renal biomarkers. Current evidence is supportive of lead exposure contributing to an increased risk of kidney disease; however, the lack of consistent findings suggests potential limitations among study designs and the magnitude of this association is unclear.
Six of six studies reviewed reported an association between cadmium levels and A1M, RBP, NAG, β2MG, urine albumin, urine protein, and eGFR. Overall, there is suggestive evidence of an effect of early life cadmium exposure measured in urine or blood on a variety of renal health outcomes.
Four of six studies reviewed reported an association between mercury levels and albumin, β2MG, NAG, GST-α, and GST-π levels. This evidence comes from randomized trials such as the Casa Pia study and the New England Children's Amalgam Trial. Another study found an association between urine mercury and β2MG and NAG levels. Overall, there is evidence suggestive of an effect of mercury exposure on renal health outcomes.
Three out of three studies reported an association of PFOA compounds with eGFR or serum uric acid levels. All three studies were conducted in the United States and controlled for possible confounders. This suggests that there may be an association between PFOA and kidney function. However, the literature on PFOA and kidney function remains fairly limited, and may be influenced by publication bias.
We identified two studies that showed a positive association between fluoride levels and urine NAG levels. This suggests that there is a possible association between fluoride and kidney function. We identified 2 studies that showed an association between Bisphenol A compounds and urine albumin levels. However, the literature on both fluoride and Bisphenol A and kidney function remains limited. We identified two studies that investigated the health effects of melamine exposure. Both found incidences of impaired kidney function and one found an association between melamine consumption and kidney stones. However, one of these studies came from a widely publicized case of melamine contamination of baby formula where the exposures were orders of magnitude higher than the other study. In this case, the link between the melamine exposure and the kidney stones was very clear as the stones were atypical in size and composition (composed of powdered melamine) compared to other kidney stones. This acute exposure to melamine was very likely the cause of these kidney stones.
We identified three publications representing two studies that investigated the health effects of smoking exposure. One study found no difference in kidney volume by maternal smoking levels, but found an association between maternal smoking and child eGFR levels. Another study found that high levels of serum cotinine were associated with a decrease in eGFR. This suggests a possible association between smoking exposures and kidney function, however the literature remains limited.
Both studies of arsenic exposure found no association between urine arsenic and eGFR. Additional environmental chemicals of concern have only been examined in single studies to date. These include metals such as uranium, thallium, selenium, and manganese, as well as non-metal compounds such as aflatoxin and ochratoxin, triclosan, and Benzophenone-3. However, the literature is limited and more research will need to be conducted.
Gaps and limitations of existing research
Our review identified several gaps in scientific knowledge. These include a critical need for additional studies of environment chemicals exposures and renal health, including but not limited to lead, arsenic, manganese, cadmium, fluoride, Bisphenol A, PFOA, and PAH compounds. There is also a need for research on other environmental exposure combinations such as urbanization. A study in China found an association between urbanized and reduced eGFR in adults (Inoue et al., 2017) . However, few studies have examined this exposure and this may be a potential risk factor for children. Additionally, it is clear that studies on children's renal health suffer from a lack of unified outcome measures. Diverse outcomes, including albuminuria, eGFR, NAG, β2MG, RBP, GST-α, GST-π, serum creatinine, serum urea, kidney size, urine protein, and blood urea nitrogen levels are currently used as markers of renal health. These markers themselves are imprecise, limiting analysis to larger effect sizes or requiring very large cohorts. Appropriate exposure assessment and appropriate use of adjustment for urine dilution remains controversial (adjustment for urinary concentration in statistical modeling versus simple ratios, urine osmolality, urine flow rates are all used in exposure assessment and have yet to be standardized). The pediatric setting, particularly the use of different definitions/equations for estimated GFR in children remains challenging to compare studies which define eGFR with different formulas. There is also complexity in using urinary concentration of toxins as measures of exposure in that the renal effects may impact urinary concentrating ability and other renal tubular functions (Weaver et al., 2016; Yeh et al., 2015; Weaver et al., 2014) . In addition, the presence of so many different outcome measures precluded the possibility of metaanalysis. The need for improved and validated biomarkers (or combinations of biomarkers) is a priority of the NIDDK, and future studies should strive to standardize renal function measures that will enable cross-study comparison.
This systematic review found limitations in the design of current epidemiologic studies of environmental exposures and renal health.
These limitations include a limited number of prospective studies and randomized clinical trials, relatively small study populations, lack of unified outcome measures, and a lack of adjustment for possible confounders. Other limitations included poor exposure assessment (some studies used proxies such as dental procedures or questionnaire, and others examined geographic areas as a proxy for exposure), and lack of precision of exposure timing (few studies collected longitudinal exposure data). No studies examined critical window methods as most exposures were assessed at baseline study visit(s).
This review also found several strengths in the current epidemiologic literature. A strength of the studies we reviewed was that most exposures were measured at the individual level using validated biomarkers. As human exposure to environmental chemicals is ubiquitous, understanding the effects on kidney disease and kidney function in children would contribute to potentially preventable disease worldwide. Another strength was that most studies used biomarkers to assess renal function, despite a lack of uniform outcome measures. Several of the studies were conducted in the general US population, therefore allowing results to be easily generalizable in the United States. Overall, due to the limitations of the existing literature, such as small sample size, cross-sectional design, and lack of adjustment for potential confounders, we were unable to make definitive inferences on these environmental chemicals.
Future perspectives
Due to the gaps and limitations of the scientific literature on environmental chemical exposure and childhood kidney disease and dysfunction, we propose that investigators should conduct additional research in this area and suggest guidelines for future studies: (1) conduct prospective studies, (2) collect longitudinal biomarkers to assess exposure, (3) standardize renal biomarkers (e.g. albuminuria, eGFR, NAG, or β2MG) to facilitate comparisons across study populations. The addition of studies meeting these guidelines will help to further the scientific knowledge of environmental exposures and pediatric renal health.
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